The Antioxidant and Antiatherogenic Effects of MAK-4 In WHHL Rabbits
- 1 December 1996
- journal article
- Published by Mary Ann Liebert Inc in The Journal of Alternative and Complementary Medicine
- Vol. 2 (4) , 463-478
- https://doi.org/10.1089/acm.1996.2.463
Abstract
Oxidized low-density lipoprotein (ox-LDL) plays an important role in atherogenesis. Atheroma formation is reduced significantly in Watanabe heritable hyperlipidemic (WHHL) rabbits by antioxidants such as probucol and vitamin E. The herbal mixture Maharishi Amrit Kalash-4 (MAK-4) inhibits Cu+2 -induced LDL oxidation, and enzymatic- and nonenzymatic-induced microsomal lipid peroxidation. We tested the effect of MAK-4 on the development of atheroma in WHHL rabbits. Eleven rabbits were divided into two groups: controls (n = 5) and a group fed 6% (w/w) MAK-4 (n = 6). Blood was drawn for biochemical analysis every two months and at necropsy, six months after the special diet was started. The aortas were preserved in formalin. The percentage area of aortic arch covered with visible plaque in the MAK-4 group (22.5 +/- 4.2%, mean +/- SE) was significantly reduced (p < 0.01) compared to the control group (47.6 +/- 6.8%, mean +/- SE). The MAK-4 group showed a significant decrease (p < 0.05) in lipid peroxide, and a significant increase (p < 0.05) in glutathione peroxidase and resistance of LDL to endothelial cell-induced and cupric ion-catalyzed oxidation (4.5 h and 5 h lag phase, respectively, for the MAK-4 group; 0 h lag phase for both for the controls). These findings suggest MAK-4 reduces atheroma formation through its antioxidant activity.Keywords
This publication has 53 references indexed in Scilit:
- The Effect of α-Tocopherol Supplementation on LDL OxidationArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit — long-term antiatherogenic effect and effects on established plaquesAtherosclerosis, 1992
- Recent Evidence for the Involvement of Catecholamines and the Macrophages in Atherosclerotic ProcessesAnnals of Medicine, 1991
- Probucol: Pharmacology and Clinical ApplicationThe Journal of Clinical Pharmacology, 1990
- Book ReviewAmbulatory Pediatric CareNew England Journal of Medicine, 1989
- Prevention of atherosclerotic progression in Watanabe rabbits by probucolThe American Journal of Cardiology, 1988
- In vivo inhibition of foam cell development by probucol in Watanabe rabbitsThe American Journal of Cardiology, 1988
- Preventive effect of pravastatin sodium, a potent inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on coronary atherosclerosis and xanthoma in WHHL rabbitsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Defective Lipoprotein Receptors and AtherosclerosisNew England Journal of Medicine, 1983
- Corticosteroid, catecholamine and glucose plasma levels in rabbits after repeated exposure to a novel environment or administration of (1–24)ACTH or insulinLife Sciences, 1982